Smith, L.; Mosley, J.; Yates, J.; Caswell, L. The New Face of Hyperlipidemia Management: Proprotein Convertase Subtilisin Kexin Inhibitors (PCSK-9) and Their Emergent Role As An Alternative To Statin Therapy. J Pharm Pharm Sci 2016, 19, 137-146.